AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
Related topics
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021

July 13, 2021 GMT

SAN DIEGO--(BUSINESS WIRE)--Jul 13, 2021--

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the second quarter 2021 following the close of market on Thursday, August 5, 2021.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Thursday, August 5, 2021. Interested parties may access the live teleconference through the Investor Info section of Illumina’s website under the “company” tab at www.illumina.com. Alternatively, individuals can access the call by dialing 1 (866) 211-4597 or 1 (647) 689-6853 outside North America, both with Conference ID 2850779. To ensure timely connection, please dial in at least ten minutes before the scheduled start of the call.

ADVERTISEMENT

A replay of the conference call will be posted on Illumina’s website after the event and will be available for at least 30 days following.

About Illumina

ADVERTISEMENT

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210713006130/en/

CONTACT: Investors:

Brian Blanchett

+1.858.291.6421

ir@illumina.com

Media:

Dr. Karen Birmingham

+1.646.355.2111

kbirmingham@illumina.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES GENETICS RESEARCH SCIENCE BIOTECHNOLOGY

SOURCE: Illumina, Inc.

Copyright Business Wire 2021.

PUB: 07/13/2021 05:00 PM/DISC: 07/13/2021 05:02 PM

http://www.businesswire.com/news/home/20210713006130/en